Imatinib Induced Psoriasis in Two Patients with Chronic Myeloid Leukemia
Journal Title: Scholars Journal of Medical Case Reports - Year 2018, Vol 6, Issue 8
Abstract
Imitanib or GlivecĀ® is a thyrosine kinase receptor inhibitor that has revolutionized the prognosis of chronic myeloid leukemia and gastrointestinal stromal tumors. This molecule is not devoid of cutaneous adverse effects. We report two cases of Imatinib-induced psoriasis, successfully managed by topical steroids. The aim of this work was to highlight the main features of Imatinib induced Psoriasis, through a systematic review of cases published in the medical literature, to enable rapid diagnosis and appropriate management of this adverse effect.
Authors and Affiliations
Zineb RACHADI, Said AMAL, Ouafa HOCAR
Juxta Axillary Granular Cell Tumor
Granular cell tumors or Abrikossoff tumors are very rare, benign and unique tumors in the vast majority of cases, described for the first time in 1926, and can mimicking carcinoma clinically and radiologically. The commo...
Fronto-nasal Encephalocele and Hypertelorism in a Newborn: Surgical Management and Case Report
Abstract: Encephalocele is described as a protrusion of cranial contents (meninges and brain tissue) through a congenital or acquired defect of the skull. Congenitalis is due to a multifactorial neural tube defect. In th...
Surgical Treatment in Inflammatory Colitis (Retrospective Study of 13 Cases)
Inflammatory colitis are inflammatory bowel disease. They are medico-surgical affections; their treatment is initially medical and become surgical in the event of complications or failure of medical treatment. This is re...
The Role of Inflammation in Essential Thrombocythemia Associated with Ischemic Heart Disease
It is accepted that in essential thrombocythemia there is an inflammatory status possibly responsible even for the disease appearance that predisposes to genomic instability (with possible new cancers) and promotes early...
Cellualr Leiomyoma in a 35 Year Old Female
Leiomyomas or fibromyomas , commonly called as fibroids are the most common uterine tumours of smooth muscle origin, often admixed with variable amount of fibrous tissue component. About 20% of women above the age of 30...